Unlike prescription GLP-1 drugs such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), these supplements lack rigorous clinical evidence and regulatory oversight
GLP-1 agonists as a class offer substantial benefits, including improved glycemic control, weight reduction, and cardiovascular protection, that millions of Americans have come to rely on, and semaglutide brands such as Ozempic and Wegovy have emerged as the drugs of choice for most patients
Theyre not necessarily associated with voice overuse
At JosephCareRX, patient safety and well-being are our top priorities
Strains of these bacteria have also been linked to weight loss, though we need clinical trials to develop recommendations for probiotics and weight loss
Glucagon-like peptide-1 mimetics improve certain cardiovascular risk factors, although it is unclear if the observed benefits are direct effects or indirect effects due to weight loss